Concentrix (NASDAQ:CNXC) Issues FY 2026 Earnings Guidance

Concentrix (NASDAQ:CNXCGet Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 11.480-12.070 for the period. The company issued revenue guidance of $10.0 billion-$10.2 billion. Concentrix also updated its Q1 2026 guidance to 2.570-2.690 EPS.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CNXC shares. Barrington Research reissued an “outperform” rating and issued a $62.00 price objective on shares of Concentrix in a research note on Monday. Robert W. Baird cut their price objective on Concentrix from $75.00 to $62.00 and set an “outperform” rating on the stock in a research report on Monday, September 29th. Canaccord Genuity Group reiterated a “buy” rating and set a $80.00 target price on shares of Concentrix in a research report on Tuesday, September 23rd. Weiss Ratings raised shares of Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Finally, Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a report on Saturday, October 25th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $66.25.

Check Out Our Latest Report on Concentrix

Concentrix Price Performance

CNXC opened at $40.48 on Tuesday. Concentrix has a 1 year low of $31.63 and a 1 year high of $66.00. The business’s 50-day moving average is $38.43 and its two-hundred day moving average is $46.77. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.56 and a quick ratio of 1.56. The firm has a market capitalization of $2.52 billion, a PE ratio of 8.56, a price-to-earnings-growth ratio of 0.59 and a beta of 0.48.

Concentrix (NASDAQ:CNXCGet Free Report) last released its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.93 by $0.02. Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The business had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.54 billion. During the same period in the previous year, the company earned $3.26 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Research analysts anticipate that Concentrix will post 10.11 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Christopher A. Caldwell acquired 1,000 shares of the business’s stock in a transaction dated Friday, October 31st. The shares were acquired at an average cost of $40.00 per share, with a total value of $40,000.00. Following the completion of the acquisition, the chief executive officer owned 287,661 shares of the company’s stock, valued at approximately $11,506,440. This trade represents a 0.35% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 3.20% of the company’s stock.

More Concentrix News

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
  • Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
  • Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
  • Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
  • Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
  • Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
  • Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi‑year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.

Institutional Trading of Concentrix

Several large investors have recently made changes to their positions in the business. AQR Capital Management LLC grew its stake in Concentrix by 1.8% in the 3rd quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock valued at $202,175,000 after acquiring an additional 75,352 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Concentrix by 18.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,939,492 shares of the company’s stock valued at $89,515,000 after purchasing an additional 301,550 shares in the last quarter. State Street Corp grew its position in shares of Concentrix by 8.7% in the second quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after purchasing an additional 130,529 shares during the period. First Trust Advisors LP grew its position in shares of Concentrix by 8.5% in the third quarter. First Trust Advisors LP now owns 585,308 shares of the company’s stock valued at $27,012,000 after purchasing an additional 46,102 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Concentrix by 75.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after purchasing an additional 181,546 shares during the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Articles

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.